These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 23307543)
41. Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database. Sonawane KB; Cheng N; Hansen RA J Manag Care Spec Pharm; 2018 Jul; 24(7):682-690. PubMed ID: 29952714 [TBL] [Abstract][Full Text] [Related]
42. Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: an overview of reports, 2003-2007. Johann-Liang R; Wyeth J; Chen M; Cope JU Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):24-7. PubMed ID: 19009550 [TBL] [Abstract][Full Text] [Related]
43. Cardiovascular thromboembolic events associated with febuxostat: investigation of cases from the FDA adverse event reporting system database. Gandhi PK; Gentry WM; Bottorff MB Semin Arthritis Rheum; 2013 Jun; 42(6):562-6. PubMed ID: 23352248 [TBL] [Abstract][Full Text] [Related]
44. Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse. Swank KA; Wu E; Kortepeter C; McAninch J; Levin RL J Am Pharm Assoc (2003); 2017; 57(2S):S63-S67. PubMed ID: 28073687 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of dabigatran bleeding adverse reaction reports in the FDA adverse event reporting system during the first year of approval. McConeghy KW; Bress A; Qato DM; Wing C; Nutescu EA Pharmacotherapy; 2014 Jun; 34(6):561-9. PubMed ID: 24644100 [TBL] [Abstract][Full Text] [Related]
46. Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System. Ross MP; Ferguson M; Street D; Klontz K; Schroeder T; Luccioli S J Allergy Clin Immunol; 2008 Jan; 121(1):166-71. PubMed ID: 18206508 [TBL] [Abstract][Full Text] [Related]
47. Outpatient insulin-related adverse events due to mix-up errors: Findings from two national surveillance systems, United States, 2012-2017. Geller AI; Conrad AO; Weidle NJ; Mehta H; Budnitz DS; Shehab N Pharmacoepidemiol Drug Saf; 2021 May; 30(5):573-581. PubMed ID: 33625786 [TBL] [Abstract][Full Text] [Related]
48. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004). DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583 [TBL] [Abstract][Full Text] [Related]
49. Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration. Hartnell NR; Wilson JP Pharmacotherapy; 2004 Jun; 24(6):743-9. PubMed ID: 15222664 [TBL] [Abstract][Full Text] [Related]
50. Effect of cough and cold medication restriction and label changes on pediatric ingestions reported to United States poison centers. Mazer-Amirshahi M; Reid N; van den Anker J; Litovitz T J Pediatr; 2013 Nov; 163(5):1372-6. PubMed ID: 23769500 [TBL] [Abstract][Full Text] [Related]
51. Nitrous oxide misuse reported to two United States data systems during 2000-2019. Forrester MB J Addict Dis; 2021; 39(1):46-53. PubMed ID: 32875958 [No Abstract] [Full Text] [Related]
52. Potentially inappropriate concomitant medicine use with the selective COX-2 inhibitor celecoxib: Analysis and comparison of spontaneous adverse event reports from Australia, Canada and the USA. Baselyous Y; De Cocinis M; Ibrahim M; Kalra A; Yacoub R; Ahmed R Expert Opin Drug Saf; 2019 Mar; 18(3):153-161. PubMed ID: 30929580 [TBL] [Abstract][Full Text] [Related]
53. Methadone Prescribing and Overdose and the Association with Medicaid Preferred Drug List Policies - United States, 2007-2014. Faul M; Bohm M; Alexander C MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(12):320-323. PubMed ID: 28358791 [TBL] [Abstract][Full Text] [Related]
55. Adverse drug event-related emergency department visits associated with complex chronic conditions. Feinstein JA; Feudtner C; Kempe A Pediatrics; 2014 Jun; 133(6):e1575-85. PubMed ID: 24843054 [TBL] [Abstract][Full Text] [Related]
56. Standardizing drug adverse event reporting data. Wang L; Jiang G; Li D; Liu H Stud Health Technol Inform; 2013; 192():1101. PubMed ID: 23920875 [TBL] [Abstract][Full Text] [Related]
57. FDA turns to electronic "sentinel" to flag prescription drug safety problems. Kuehn BM JAMA; 2008 Jul; 300(2):156-7. PubMed ID: 18612108 [No Abstract] [Full Text] [Related]
59. Ingestion of Over-the-Counter Liquid Medications: Emergency Department Visits by Children Aged Less Than 6 Years, 2012-2015. Lovegrove MC; Weidle NJ; Budnitz DS Am J Prev Med; 2019 Feb; 56(2):288-292. PubMed ID: 30573336 [TBL] [Abstract][Full Text] [Related]
60. Central nervous system-active drug abused and overdose in children: a worldwide exploratory study using the WHO pharmacovigilance database. Carnovale C; Mahzar F; Scibelli S; Gentili M; Arzenton E; Moretti U; Leoni O; Pozzi M; Peeters GGAM; Clementi E; Medaglia M; Radice S Eur J Pediatr; 2019 Feb; 178(2):161-172. PubMed ID: 30374752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]